Here are four notes:
1. The market will likely grow at a compound annual growth rate of 5.91 percent through 2020.
2. Outpatient spine surgery will boost the market, as it offers cost savings.
3. Spinal implant complications may hinder market growth.
4. Dominant vendors include West Chester, Pa.-based DePuy Synthes; Dublin, Ireland-based Medtronic; San Diego-based NuVasive; Kalamazoo, Mich.-based Stryker; and Warsaw, Ind.-based Zimmer Biomet.
More articles on devices:
Hip, knee orthopedic surgical implants to surge to $33B by 2022; Zimmer Biomet dominating market — 5 things to know
Bioventus appoints John Nosenzo new chief commercial officer: 7 thoughts
Xtant Medical CEO Dan Goldberger resigns: 5 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
